St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Children’s Research Hospital has offered bone marrow transplants since 1982 for the treatment of cancer, blood, immune, and other disorders.
A bone marrow transplant (also known as a stem cell transplant) replaces diseased or damaged blood-forming stem cells with healthy cells from your child or a donor. The cells are called hematopoietic stem cells. They mature and develop into all the other blood cells, including red blood cells, white blood cells and platelets.
Bone marrow is the main source of these stem cells. The marrow is the spongy area inside the bones. Bone marrow transplants are also called stem cell transplants, hematopoietic stem cell transplants, or blood and marrow transplants.
Bone marrow transplants are defined by the source of the donor cells:
St. Jude has one of the world’s largest bone marrow transplant programs that treats only children, teens, and young adults. Our doctors have been pioneers in bone marrow transplantation for more than 40 years.
Your child will get the type of bone marrow transplant that best treats their disease.
Autologous bone marrow transplants may treat:
Allogeneic bone marrow transplants may treat:
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults who need bone marrow transplants. Learn more about clinical research at St. Jude.
Study goal:
The main goal of this study is to learn more about the effects (good and bad) of this treatment in children and young adults with high-risk blood disorders.
Age:
21 years old and younger
Study goal:
The purpose of this study is to collect information from the medical records of patients receiving an unrelated transplant. Information in this research database may be helpful towards improving the results of future patients receiving transplants.
Study goal:
Determine the optimal, upfront therapy for pediatric SAA in the absence of a matched sibling donor.
Age:
Up to 25 years old
Study goal:
The main goal of this study is to learn the largest dose of memory CAR T cells that can be safely given. Researchers also want to learn about the way memory CAR T cells act in the body and how effectively they treat this type of cancer.
Age:
Donor: At least 19 years old; Recipient: 21 years or younger
Study goal:
To see if motixafortide is safe and helps increase collection of stem cells in adults with sickle cell disease. Learn more about the study.
Age:
Age 18 and older
St. Jude provides the highest quality of care for patients having bone marrow transplants.
Your child will be assigned a bone marrow transplant doctor and a nurse practitioner or physician assistant. They will oversee your child’s care. The team caring for your child also includes other medical staff, researchers, and care team members. They all have special training in bone marrow transplant care and treatment.
Before the transplant, your child will have many tests, including blood work and tests to check the health of major organs. You will also meet with members of our support teams.
Your child must have a central line for transplant. This allows your child to easily give blood samples and receive medicines. It also eliminates the need for most needle sticks.
Depending on the type of transplant your child has, the stem cells are either collected locally or shipped to St. Jude. The cells may be collected from the bone marrow or from blood in the veins (peripheral blood).
Cells for autologous bone marrow transplants are collected from your child weeks to months ahead of transplant. The cells are then stored until they are needed. Donor cells for allogeneic transplants are usually collected within a few days of transplant. The cells used for both autologous and allogenic transplant are processed in our Human Applications Laboratory before being given to the patient.
Your child will typically be admitted to the St. Jude Transplant Unit the day before the conditioning regimen begins. The conditioning regimen is also known as the preparative regimen. It is a key part of the transplant.
The process prepares your child’s body to receive the donor cells by making space in the marrow for new cells. Sometimes the conditioning regimen also means killing any cancer or abnormal cells that are present.
The conditioning regimen may include chemotherapy, and radiation. Sometimes it also involves antibody therapies. The preparation is typically given over 5–14 days, depending on the type of transplant your child will have.
On the day of the transplant, the stem cells are given in your child’s room. The cells are given through a vein or central line, in a process much like a blood transfusion. The cells then travel through the bloodstream to the center of the long bones. There they begin to grow.
The new cells will take several weeks to grow enough to be able to measure them with a blood test. Your child will remain in the hospital until they have recovered from the transplant. That often takes at least 4–6 weeks. If problems occur, the hospital stay may be longer.
Infection prevention is crucial during your child’s recovery. The Transplant Unit staff will explain how you and other visitors can help keep your child safe during recovery.
Learn more about the St. Jude Transplant Unit
Bone marrow transplants are sometimes unsuccessful because the disease returns, or severe treatment-related side effects develop.
The type and frequency of possible side effects varies depending on:
Possible side effects will be discussed by your child’s care team throughout treatment. Side effects include:
When your child is ready to leave the hospital, specialists from different departments will meet with you to plan your child’s discharge. They will also explain how to care for your child after leaving the hospital.
After an allogeneic transplant, children usually stay close to the hospital for at least 100 days after leaving the hospital. That allows us to monitor their recovery. During this time we provide housing for families who do not live in Memphis.
Once your child is safe to return home, your child’s St. Jude doctor will send a letter to the care provider who referred your child for treatment. The letter will outline your child’s treatment.
If your child has an autologous transplant, your child will be seen in our transplant clinic until they have recovered. Then they will be transferred to the care provider who referred them for treatment.